Exopharm Limited

Exopharm Limitedverified

EX1.AX

Price:

$0.011

Market Cap:

$1.93M

Exopharm Limited, a clinical-stage company, develops transformative medicines based upon extracellular vesicles (EVs) in Australia. The company's technology includes extracellular vesicle positioning system that allows specific molecules to be attached to the surface of exosomes to guide them to target tissues or cell types; leveraging oligonucleotide packing for amplified dosing, which enables specific RNA molecules to be preferentially loaded into exosomes as a therapeutic cargo; ligand-based exosome affinity purification that isolates and purifies exosomes from biofluids like blood and cell culture media. Its engineered EVs products comprise Fortrexo CoV for the treatment of SARS-CoV-2 in...[Read more]

Industry

Biotechnology

IPO Date

2018-12-17

Stock Exchange

ASX

Ticker

EX1.AX

The Current Ratio as of November 2025 (TTM) for Exopharm Limited (EX1.AX) is 2.67

According to Exopharm Limited’s latest financial reports and current stock price. The company's current Current Ratio is 2.67. This represents a change of -24.84% compared to the average of 3.56 of the last 4 quarters.

Exopharm Limited (EX1.AX) Historical Current Ratio (quarterly & annually)

How has EX1.AX Current Ratio performed in the past?

The mean historical Current Ratio of Exopharm Limited over the last ten years is 14.60. The current 2.67 Current Ratio has changed 1.73% with respect to the historical average. Over the past ten years (40 quarters), EX1.AX's Current Ratio was at its highest in in the June 2018 quarter at 96.15. The Current Ratio was at its lowest in in the December 2014 quarter at 0.

Quarterly (TTM)
Annual

Average

14.60

Median

2.67

Minimum

0

Maximum

96.15

Exopharm Limited (EX1.AX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Exopharm Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Current Ratio = 96.15

Minimum Annual Increase = 0%

Minimum Annual Current Ratio = 0

Quarterly (TTM)
Annual
YearCurrent RatioChange
20232.6726.16%
20222.12-78.20%
20219.72120.77%
20204.40-72.98%
201916.30-83.04%
201896.15Infinity%
201700%
201600%

Exopharm Limited (EX1.AX) Average Current Ratio

How has EX1.AX Current Ratio performed in the past?

The current Current Ratio of Exopharm Limited (EX1.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.84

5-year avg

7.05

10-year avg

14.60

Exopharm Limited (EX1.AX) Current Ratio vs. Peers

How is EX1.AX’s Current Ratio compared to its peers?

Exopharm Limited’s Current Ratio is less than Hexima Limited (27.08), greater than Wellfully Limited (0.58), less than The Sustainable Nutrition Group Ltd (2.94), less than Health House International Limited (0), greater than Regeneus Ltd (0.28), greater than Jayex Technology Limited (0.08), greater than Uscom Limited (0.95), less than Total Brain Limited (3.31), greater than Allegra Medical Technologies Limited (1.28), greater than Medibio Limited (1.86),

Build a custom stock screener for Exopharm Limited (EX1.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exopharm Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Exopharm Limited (EX1.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Exopharm Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Exopharm Limited's Current Ratio?

How is the Current Ratio calculated for Exopharm Limited (EX1.AX)?

What is the highest Current Ratio for Exopharm Limited (EX1.AX)?

What is the 3-year average Current Ratio for Exopharm Limited (EX1.AX)?

What is the 5-year average Current Ratio for Exopharm Limited (EX1.AX)?

How does the current Current Ratio for Exopharm Limited (EX1.AX) compare to its historical average?